Post-transplant hyperlipidemia | Zendy

Ziad A. Massy | Zendy; B.L. Kasiske | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Post-transplant hyperlipidemia

Author(s) -

Ziad A. Massy,

B.L. Kasiske

Publication year - 1996

Publication title -

journal of the american society of nephrology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 4.451

H-Index - 279

eISSN - 1533-3450

pISSN - 1046-6673

DOI - 10.1681/asn.v77971

Subject(s) - hyperlipidemia , medicine , transplantation , renal transplant , clinical trial , disease , kidney disease , chronic renal disease , population , kidney transplantation , lipid profile , intensive care medicine , cholesterol , endocrinology , diabetes mellitus , environmental health

Hyperlipidemia is common after renal transplantation. In recent years, much progress has been made in understanding the causes and treatment of lipid abnormalities in renal transplant patients. Recently, short-term studies have shown that newer antilipemic agents appear to be safe and effective in treating hyperlipidemia in this population. Despite the absence of large, controlled clinical trials examining the effect of lipid-lowering strategies on cardiovascular disease and chronic renal allograft rejection, therapy appears to be warranted in renal transplant patients with an atherogenic lipid profile and multiple risk factors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research